BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23326303)

  • 21. Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4).
    Woodard LE; De Silva RA; Behnam Azad B; Lisok A; Pullambhatla M; G Lesniak W; Mease RC; Pomper MG; Nimmagadda S
    Nucl Med Biol; 2014 Aug; 41(7):552-61. PubMed ID: 25038987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications.
    Gaonkar RH; Schmidt YT; Mansi R; Almeida-Hernandez Y; Sanchez-Garcia E; Harms M; Münch J; Fani M
    J Med Chem; 2023 Jul; 66(13):8484-8497. PubMed ID: 37328158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction.
    Thackeray JT; Derlin T; Haghikia A; Napp LC; Wang Y; Ross TL; Schäfer A; Tillmanns J; Wester HJ; Wollert KC; Bauersachs J; Bengel FM
    JACC Cardiovasc Imaging; 2015 Dec; 8(12):1417-1426. PubMed ID: 26577262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.
    Hanaoka H; Mukai T; Tamamura H; Mori T; Ishino S; Ogawa K; Iida Y; Doi R; Fujii N; Saji H
    Nucl Med Biol; 2006 May; 33(4):489-94. PubMed ID: 16720240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery.
    Debie P; Declerck NB; van Willigen D; Huygen CM; De Sloovere B; Mateusiak L; Bridoux J; Puttemans J; Devoogdt N; van Leeuwen FWB; Hernot S
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33652977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo detection of small tumour lesions by multi-pinhole SPECT applying a (99m)Tc-labelled nanobody targeting the Epidermal Growth Factor Receptor.
    Krüwel T; Nevoltris D; Bode J; Dullin C; Baty D; Chames P; Alves F
    Sci Rep; 2016 Feb; 6():21834. PubMed ID: 26912069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
    Buckle T; van Willigen DM; Spa SJ; Hensbergen AW; van der Wal S; de Korne CM; Welling MM; van der Poel HG; Hardwick JCH; van Leeuwen FWB
    J Nucl Med; 2018 Jun; 59(6):986-992. PubMed ID: 29449447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.
    De Silva RA; Peyre K; Pullambhatla M; Fox JJ; Pomper MG; Nimmagadda S
    J Nucl Med; 2011 Jun; 52(6):986-93. PubMed ID: 21622896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [
    Derlin T; Sedding DG; Dutzmann J; Haghikia A; König T; Napp LC; Schütze C; Owsianski-Hille N; Wester HJ; Kropf S; Thackeray JT; Bankstahl JP; Geworski L; Ross TL; Bauersachs J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1934-1944. PubMed ID: 29967943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorophore labeling enables imaging and evaluation of specific CXCR4-ligand interaction at the cell membrane for fluorescence-based screening.
    Nomura W; Tanabe Y; Tsutsumi H; Tanaka T; Ohba K; Yamamoto N; Tamamura H
    Bioconjug Chem; 2008 Sep; 19(9):1917-20. PubMed ID: 18707146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
    Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
    Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodinated Pentixather for SPECT Imaging of Expression of the Chemokine Receptor CXCR4 in Rat Myocardial-Infarction-Reperfusion Models.
    Li J; Peng C; Guo Z; Shi C; Zhuang R; Hong X; Wang X; Xu D; Zhang P; Zhang D; Liu T; Su X; Zhang X
    Anal Chem; 2018 Aug; 90(15):9614-9620. PubMed ID: 29996650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multimodality labeling strategies for the investigation of nanocrystalline cellulose biodistribution in a mouse model of breast cancer.
    Sarparanta M; Pourat J; Carnazza KE; Tang J; Paknejad N; Reiner T; Kostiainen MA; Lewis JS
    Nucl Med Biol; 2020; 80-81():1-12. PubMed ID: 31759312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
    Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
    Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Vallejo-Armenta P; Santos-Cuevas C; Soto-Andonaegui J; Villanueva-Pérez RM; González-Díaz JI; García-Pérez FO; Arrellano-Zarate A; Luna-Gutiérrez M; Azorín-Vega E; Ocampo-García B; Ferro-Flores G
    Contrast Media Mol Imaging; 2020; 2020():2525037. PubMed ID: 32410920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Contrast CXCR4-Targeted
    Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
    Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent.
    Gourni E; Demmer O; Schottelius M; D'Alessandria C; Schulz S; Dijkgraaf I; Schumacher U; Schwaiger M; Kessler H; Wester HJ
    J Nucl Med; 2011 Nov; 52(11):1803-10. PubMed ID: 22045709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
    Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide.
    Edwards WB; Akers WJ; Ye Y; Cheney PP; Bloch S; Xu B; Laforest R; Achilefu S
    Mol Imaging; 2009; 8(2):101-10. PubMed ID: 19397855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model.
    Guan G; Lu Y; Zhu X; Liu L; Chen J; Ma Q; Zhang Y; Wen Y; Yang L; Liu T; Wang W; Ran H; Qiu X; Ke S; Zhou Y
    Sci Rep; 2015 Oct; 5():15244. PubMed ID: 26472699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.